Title: E-Daily– LegoChem applies for preliminary evaluation for special IPO.
Publication: E-Daily
Date: 01 October 2011
Summary
LegoChem
Bioscience applied for preliminary evaluation and will continue to prepare for
special IPO in KOSDAQ. LegoChem is a
qualified company for New Growth Engine special IPO evaluation. The company
signed IPO supervision contract last year and passed the technology evaluation
this year.
To view the full article
(in Korean), click here ▶
About
LegoChem Biosciences
LegoChem
Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to
discovering, developing, and commercializing innovative medicines by leveraging
our chemistry expertise to make conventional biologics targeted and more potent
for the benefit of patients with diseases of high unmet medical needs. We are
advancing sustainable pipelines in therapeutic areas in antibiotics,
anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug
conjugate (PDC).
|
|
IP : 106.243.208.*** 
|
